FEATURED EDITORIAL
Johns Hopkins investigators discuss gaps in women’s health research and how their work addresses endometrial dysfunction and infertility through precision nanomedicine.
- Rethinking Disease Modification Through Targeted Immunotherapy
- New Approach Methods In Practice: Where Are We Today?
- Insights From The Non-Opioid Pain Therapeutics Summit: Human-Centric Translational Models And The Reawakening Of Pain Pipelines
- AI For NAM-Ready Drug Development: Turning Promise Into Trust
- From Cyclization To The Clinic: The Rising Era Of Cyclic Peptide Therapeutics
- Targeting Underlying Biology: Novel Combination Therapies For Chronic Disease
- Schrödinger's Equation Turns 100: How Quantum Chemistry Is Improving Drug Discovery
FEATURED APPLICATION CONTENT
-
Explore how leveraging expert CDMO partnerships can streamline the development process and enhance the efficacy of your bispecific antibody therapies.
-
Consider this alternative immunization approach — the PentaMice platform, a collection of five wildtype mouse strains bred in-house for increased MHC class II diversity — and how we're leveraging it for COVID-19 antibody discovery.
-
By forging strategic partnerships with comprehensive CDMOs, see how emerging biopharma firms can navigate through early-phase development and ensure a smooth transition to clinical advancement.
-
Explore how advanced single‑cell analysis links CAR localization, cell structure, and functional behavior, offering deeper insight into CAR T cell heterogeneity and performance.
-
Gain insight into automating DNA size selection that shows how optimized bead ratios and programmable handling improve fragment recovery, consistency, and throughput.
-
Gain insight into an automated high‑input workflow that streamlines long‑read whole‑genome library prep, supporting large DNA fragments while reducing reagent use.
-
A streamlined workflow reduces reagent use and hands‑on time while preserving long‑read sequencing quality. See how multiplexed offer an efficient option for scaling or mobilizing sequencing efforts.
-
Understanding covalent warhead kinetics is key to reducing safety risks early in discovery. Learn about a new approach to GSH‑based measurements that offers clearer predictors of toxicity.
-
See how a rapid digital PCR workflow enables reliable detection of trace RCL levels while maintaining strong performance in complex samples, which support more confident decisions in manufacturing.
-
Discover how mixed-mode chromatography enables high-yield purification of single-domain antibodies under mild conditions and why these approaches outperform traditional resins.
-
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Decoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.
- Insights From The Non-Opioid Pain Therapeutics Summit: Human-Centric Translational Models And The Reawakening Of Pain Pipelines
- Schrödinger's Equation Turns 100: How Quantum Chemistry Is Improving Drug Discovery
- Annual Reflections And Predictions From The Editors' Roundtable
- The Unlikely Weapon Against Fentanyl: Your Immune System
- 2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026
FEATURED NEWS HEADLINES
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Merck And Mayo Clinic Announce New Research And Development Collaboration To Support AI-Enabled Drug Discovery And Precision Medicine
- Insilico Medicine Initiates AI-Driven Collaboration With Leading Global Cancer Center To Identify Novel Targets For Gastroesophageal Cancers
- TuHURA Files Investigational New Drug Application For TBS-2025 In The Treatment Of Blood-Related Cancers
- U.S. Food And Drug Administration Accepts Bristol Myers Squibb's New Drug Application For Iberdomide In Patients With Relapsed Or Refractory Multiple Myeloma
- Harmony Biosciences Receives U.S. Food And Drug Administration Approval For WAKIX (pitolisant) For The Treatment Of Cataplexy In Pediatric Narcolepsy
- BostonGene Announces Strategic Collaboration With Daiichi Sankyo To Accelerate Drug Development Through AI-Driven Multimodal Analytics
- Deciphera Pharmaceuticals Announces U.S. Food And Drug Administration Acceptance For Filing Of New Drug Application For Tirabrutinib In Patients With Relapsed Or Refractory PCNSL
- Twist Bioscience Expands Antibody Discovery Offering With Bispecific Licensing Agreement
- Nuclera And Leadxpro Partner To Accelerate Structure-Based Drug Design For Complex Membrane Proteins
ARCHIVED NEWSLETTER
- 02.17.26 -- Avoiding Protein Purification Artifacts That Still Undermine Drug Design
- 02.10.26 -- Designing Drugs For Women: Closing The Therapeutic Gap
- 02.03.26 -- CROs In Early Drug Discovery, Part 3: Budgets, Timelines, And Avoiding Pitfalls
- 01.27.26 -- Schrödinger's Equation Turns 100: How Quantum Chemistry Is Improving Drug Discovery
- 01.20.26 -- CROs In Early Drug Discovery, Part 1: Choosing The Right Partner